Abstract
Polygenic risk score (PRS) is a tool to quantify the susceptibility of an individual to a disease by using the results of individual gene sequencing to calculate the cumulative effect of genetic susceptibility loci. In this study, we extend the individual-based PRS to the population-based mean polygenic risk score (PMPRS), Further more, we constructed the risk score ratio (RSR) for etiology exploration. In the case study, we applied above method to explore the relationship between study six inflammatory factors and coronary heart disease (CHD). Our studies have shown that tumor necrosis factor-α (TNF-α) and procalcitonin (PCT) are potential risk factors for CHD. The RSR corresponding to TNF-α is 4.97 (prediction interval: 2.99, 10.548); the RSR corresponding to PCT is 21.87 (prediction interval: 2.29, 232.28), and controlling the levels of TNF-α and PCT can be used as a primary preventive measure to reduce the occurrence of coronary heart disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
National Natural Science Foundation of China [grant number 81872715, 82073674]
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced are available online at https://gwas.mrcieu.ac.uk/ and https://www.uk10k.org/
